{"id":26425,"date":"2022-10-13T13:58:33","date_gmt":"2022-10-13T12:58:33","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=26425"},"modified":"2022-10-13T14:05:49","modified_gmt":"2022-10-13T13:05:49","slug":"reseau-emergent-antibiodeal","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/","title":{"rendered":"Participez au r\u00e9seau \u00e9mergent AntibioDEAL"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"200\" height=\"200\" src=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/image.png\" alt=\"\" class=\"wp-image-26443\" srcset=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/image.png 200w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/image-150x150.png 150w\" sizes=\"(max-width: 200px) 100vw, 200px\" \/><\/figure>\n\n\n\n<p>Afin de lutter contre l\u2019antibior\u00e9sistance, le m\u00e9ta-r\u00e9seau professionnel PROMISE a \u00e9t\u00e9 cr\u00e9\u00e9 (PPR antibior\u00e9sistance). Le r\u00e9seau \u00e9mergent AntibioDEAL s\u2019inscrit dans ce programme et s\u2019attache \u00e0 structurer la recherche et le d\u00e9veloppement d\u2019agents anti-infectieux au niveau national. Plus pr\u00e9cis\u00e9ment, AntibioDEAL a pour objectif d\u2019identifier et lever les verrous scientifiques et technologiques de la d\u00e9couverte d\u2019agents anti-infectieux et ainsi r\u00e9amorcer le pipeline pr\u00e9clinique.<\/p>\n\n\n\n<p>Nous vous proposons de rejoindre AntibioDEAL et de participer \u00e0 la structuration de la recherche jusqu&#8217;aux \u00e9valuations pr\u00e9cliniques au niveau national. Votre expertise nous aidera \u00e0 cr\u00e9er une liste pr\u00e9cise des diff\u00e9rents verrous qui freinent la recherche.<br class=\"\">Par la cr\u00e9ation de groupes de travail, nous souhaitons clarifier les standards du d\u00e9veloppement d\u2019agent anti-infectieux \u00e0 chaque \u00e9tape du d\u00e9veloppement et cr\u00e9er une liste de contacts qui permettra d\u2019accompagner vos travaux de recherche et d\u00e9veloppement.<\/p>\n\n\n\n<p>La force d\u2019AntibioDEAL repose sur l\u2019implication des acteurs de la recherche et du d\u00e9veloppement d\u2019agents anti-infectieux. N\u2019h\u00e9sitez pas \u00e0 diffuser et partager cette invitation dans vos r\u00e9seaux !<br>Pour nous rejoindre, merci de compl\u00e9ter le formulaire ci-dessous (3 min) et de le retourner \u00e0 l\u2019adresse suivante :\u00a0<a href=\"mailto:antibiodeal@unicaen.fr\">antibiodeal@unicaen.fr<\/a><br>En esp\u00e9rant vous compter prochainement parmi nous !<br>Le comit\u00e9 AntibioDEAL<\/p>\n\n\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-text-align-center\">Suivez-nous sur les r\u00e9seaux :\u00a0<a class=\"\" href=\"https:\/\/www.linkedin.com\/company\/antibiodeal\" target=\"_blank\" rel=\"noreferrer noopener\">Linkedin<\/a>\u00a0et\u00a0<a class=\"\" href=\"https:\/\/twitter.com\/AntibioDEAL\" target=\"_blank\" rel=\"noreferrer noopener\">Twitter<\/a>\u00a0!<\/p>\n\n\n\n<p><\/p>\n\n\n\n<div style=\"height:67px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>Veuillez trouver le Flyer du r\u00e9seau et le formulaire de participation ci-dessous :<\/p>\n\n\n\n<p><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\"  class=\"wp-block-file__embed\" data=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/Flyer_AntibioDEAL.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Contenu embarqu\u00e9 Embed of Flyer_AntibioDEAL..\"><\/object><a id=\"wp-block-file--media-0da54ce9-3609-478f-bdd3-05f79741a6ce\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/Flyer_AntibioDEAL.pdf\">Flyer_AntibioDEAL<\/a><a href=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/Flyer_AntibioDEAL.pdf\" class=\"wp-block-file__button\" download aria-describedby=\"wp-block-file--media-0da54ce9-3609-478f-bdd3-05f79741a6ce\">T\u00e9l\u00e9charger<\/a><\/div>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\"  class=\"wp-block-file__embed\" data=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/Formulaire_AntibioDEAL.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Contenu embarqu\u00e9 Embed of Formulaire_AntibioDEAL..\"><\/object><a id=\"wp-block-file--media-7e11b29a-1949-4425-8605-0501c4717d67\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/Formulaire_AntibioDEAL.pdf\">Formulaire_AntibioDEAL<\/a><a href=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/Formulaire_AntibioDEAL.pdf\" class=\"wp-block-file__button\" download aria-describedby=\"wp-block-file--media-7e11b29a-1949-4425-8605-0501c4717d67\">T\u00e9l\u00e9charger<\/a><\/div>\n\n\n\n<figure class=\"wp-block-gallery has-nested-images columns-default is-cropped wp-block-gallery-1 is-layout-flex wp-block-gallery-is-layout-flex\"><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Afin de lutter contre l\u2019antibior\u00e9sistance, le m\u00e9ta-r\u00e9seau professionnel PROMISE a \u00e9t\u00e9 cr\u00e9\u00e9 (PPR antibior\u00e9sistance). Le r\u00e9seau \u00e9mergent AntibioDEAL s\u2019inscrit dans ce programme et s\u2019attache \u00e0 structurer la recherche et le d\u00e9veloppement d\u2019agents anti-infectieux au niveau national. Plus pr\u00e9cis\u00e9ment, AntibioDEAL a pour objectif d\u2019identifier et lever les verrous scientifiques et technologiques de la d\u00e9couverte d\u2019agents anti-infectieux [&hellip;]<\/p>\n","protected":false},"author":271,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Participez au r\u00e9seau \u00e9mergent AntibioDEAL - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Le r\u00e9seau \u00e9mergent AntibioDEAL s\u2019inscrit dans ce programme et s\u2019attache \u00e0 structurer la recherche et le d\u00e9veloppement d\u2019agents anti-infectieux au niveau national. Plus pr\u00e9cis\u00e9ment, AntibioDEAL a pour objectif d\u2019identifier et lever les verrous scientifiques et technologiques de la d\u00e9couverte d\u2019agents anti-infectieux et ainsi r\u00e9amorcer le pipeline pr\u00e9clinique. Nous vous proposons de rejoindre AntibioDEAL et de participer \u00e0 la structuration de la recherche jusqu&#039;aux \u00e9valuations pr\u00e9cliniques au niveau national. Votre expertise nous aidera \u00e0 cr\u00e9er une liste pr\u00e9cise des diff\u00e9rents verrous qui freinent la recherche.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Participez au r\u00e9seau \u00e9mergent AntibioDEAL - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Le r\u00e9seau \u00e9mergent AntibioDEAL s\u2019inscrit dans ce programme et s\u2019attache \u00e0 structurer la recherche et le d\u00e9veloppement d\u2019agents anti-infectieux au niveau national. Plus pr\u00e9cis\u00e9ment, AntibioDEAL a pour objectif d\u2019identifier et lever les verrous scientifiques et technologiques de la d\u00e9couverte d\u2019agents anti-infectieux et ainsi r\u00e9amorcer le pipeline pr\u00e9clinique. Nous vous proposons de rejoindre AntibioDEAL et de participer \u00e0 la structuration de la recherche jusqu&#039;aux \u00e9valuations pr\u00e9cliniques au niveau national. Votre expertise nous aidera \u00e0 cr\u00e9er une liste pr\u00e9cise des diff\u00e9rents verrous qui freinent la recherche.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-13T12:58:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-13T13:05:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/image.png\" \/>\n<meta name=\"author\" content=\"Loane Serrano\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Loane Serrano\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/\"},\"author\":{\"name\":\"Loane Serrano\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/7993978f184ff491165415f02259de61\"},\"headline\":\"Participez au r\u00e9seau \u00e9mergent AntibioDEAL\",\"datePublished\":\"2022-10-13T12:58:33+00:00\",\"dateModified\":\"2022-10-13T13:05:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/\"},\"wordCount\":260,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/image.png\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/\",\"name\":\"Participez au r\u00e9seau \u00e9mergent AntibioDEAL - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/image.png\",\"datePublished\":\"2022-10-13T12:58:33+00:00\",\"dateModified\":\"2022-10-13T13:05:49+00:00\",\"description\":\"Le r\u00e9seau \u00e9mergent AntibioDEAL s\u2019inscrit dans ce programme et s\u2019attache \u00e0 structurer la recherche et le d\u00e9veloppement d\u2019agents anti-infectieux au niveau national. Plus pr\u00e9cis\u00e9ment, AntibioDEAL a pour objectif d\u2019identifier et lever les verrous scientifiques et technologiques de la d\u00e9couverte d\u2019agents anti-infectieux et ainsi r\u00e9amorcer le pipeline pr\u00e9clinique. Nous vous proposons de rejoindre AntibioDEAL et de participer \u00e0 la structuration de la recherche jusqu'aux \u00e9valuations pr\u00e9cliniques au niveau national. Votre expertise nous aidera \u00e0 cr\u00e9er une liste pr\u00e9cise des diff\u00e9rents verrous qui freinent la recherche.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/image.png\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/image.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Participez au r\u00e9seau \u00e9mergent AntibioDEAL\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/7993978f184ff491165415f02259de61\",\"name\":\"Loane Serrano\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Participez au r\u00e9seau \u00e9mergent AntibioDEAL - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Le r\u00e9seau \u00e9mergent AntibioDEAL s\u2019inscrit dans ce programme et s\u2019attache \u00e0 structurer la recherche et le d\u00e9veloppement d\u2019agents anti-infectieux au niveau national. Plus pr\u00e9cis\u00e9ment, AntibioDEAL a pour objectif d\u2019identifier et lever les verrous scientifiques et technologiques de la d\u00e9couverte d\u2019agents anti-infectieux et ainsi r\u00e9amorcer le pipeline pr\u00e9clinique. Nous vous proposons de rejoindre AntibioDEAL et de participer \u00e0 la structuration de la recherche jusqu'aux \u00e9valuations pr\u00e9cliniques au niveau national. Votre expertise nous aidera \u00e0 cr\u00e9er une liste pr\u00e9cise des diff\u00e9rents verrous qui freinent la recherche.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/","og_locale":"fr_FR","og_type":"article","og_title":"Participez au r\u00e9seau \u00e9mergent AntibioDEAL - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Le r\u00e9seau \u00e9mergent AntibioDEAL s\u2019inscrit dans ce programme et s\u2019attache \u00e0 structurer la recherche et le d\u00e9veloppement d\u2019agents anti-infectieux au niveau national. Plus pr\u00e9cis\u00e9ment, AntibioDEAL a pour objectif d\u2019identifier et lever les verrous scientifiques et technologiques de la d\u00e9couverte d\u2019agents anti-infectieux et ainsi r\u00e9amorcer le pipeline pr\u00e9clinique. Nous vous proposons de rejoindre AntibioDEAL et de participer \u00e0 la structuration de la recherche jusqu'aux \u00e9valuations pr\u00e9cliniques au niveau national. Votre expertise nous aidera \u00e0 cr\u00e9er une liste pr\u00e9cise des diff\u00e9rents verrous qui freinent la recherche.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2022-10-13T12:58:33+00:00","article_modified_time":"2022-10-13T13:05:49+00:00","og_image":[{"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/image.png"}],"author":"Loane Serrano","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Loane Serrano","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/"},"author":{"name":"Loane Serrano","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/7993978f184ff491165415f02259de61"},"headline":"Participez au r\u00e9seau \u00e9mergent AntibioDEAL","datePublished":"2022-10-13T12:58:33+00:00","dateModified":"2022-10-13T13:05:49+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/"},"wordCount":260,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/image.png","articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/","name":"Participez au r\u00e9seau \u00e9mergent AntibioDEAL - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/image.png","datePublished":"2022-10-13T12:58:33+00:00","dateModified":"2022-10-13T13:05:49+00:00","description":"Le r\u00e9seau \u00e9mergent AntibioDEAL s\u2019inscrit dans ce programme et s\u2019attache \u00e0 structurer la recherche et le d\u00e9veloppement d\u2019agents anti-infectieux au niveau national. Plus pr\u00e9cis\u00e9ment, AntibioDEAL a pour objectif d\u2019identifier et lever les verrous scientifiques et technologiques de la d\u00e9couverte d\u2019agents anti-infectieux et ainsi r\u00e9amorcer le pipeline pr\u00e9clinique. Nous vous proposons de rejoindre AntibioDEAL et de participer \u00e0 la structuration de la recherche jusqu'aux \u00e9valuations pr\u00e9cliniques au niveau national. Votre expertise nous aidera \u00e0 cr\u00e9er une liste pr\u00e9cise des diff\u00e9rents verrous qui freinent la recherche.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/image.png","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/10\/image.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/reseau-emergent-antibiodeal\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"Participez au r\u00e9seau \u00e9mergent AntibioDEAL"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/7993978f184ff491165415f02259de61","name":"Loane Serrano"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-13 22:24:59","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/26425"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/271"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=26425"}],"version-history":[{"count":8,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/26425\/revisions"}],"predecessor-version":[{"id":26457,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/26425\/revisions\/26457"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=26425"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=26425"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=26425"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}